
Buy Cartalax Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy Cartalax Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
Verify Batch
Lot-level COA, Batch DF/CAR/062026
What is Cartalax?
Cartalax is a synthetic three-amino-acid peptide (Ala-Glu-Asp) from the Russian peptide bioregulator program, designed to target cartilage and connective tissue. It is studied in laboratory research for its effects on cartilage-cell signaling.
- A short synthetic peptide (Ala-Glu-Asp) from the Russian bioregulator program
- Studied in laboratory research for its effects on cartilage and connective-tissue cell signaling
- One of a family of short peptides each studied in a specific tissue type
- Investigated alongside other organ-specific bioregulators from the same program
For research use only. Not approved for human therapeutic use.
Cartalax, also known by its tripeptide designation AED (Ala-Glu-Asp) and the developmental code T-31, is a synthetic tripeptide bioregulator with the molecular formula C12H19N3O8 and an approximate molecular weight of 333.3 g/mol. Developed at the Saint Petersburg Institute of Bioregulation and Gerontology, Cartalax was designed based on peptide fractions associated with cartilaginous tissue. Its three-amino acid sequence, Ala-Glu-Asp, shares the AED core motif found in the longer tetrapeptide bioregulators Epithalon (AEDG), Cortagen (AEDP), Cardiogen (AEDR), and Bronchogen (AEDL), representing the minimal tripeptide unit within this structural series. Produced via solid-phase peptide synthesis, Cartalax is associated with chondrocyte gene expression and cartilage matrix signaling pathways.
Cartalax is a tripeptide bioregulator within the Khavinson framework. In mesenchymal stem cell preparations, the tripeptide modulated the expression of genes governing chondrogenic differentiation and cellular metabolic activity, consistent with the Wnt, ERK-p38, and Smad signaling pathways described for chondrogenic peptides [1]. In a parallel in vitro model of mesenchymal stem cell aging in culture, AED was reported to increase IGF1 gene expression approximately 3.5- to 5.6-fold alongside stimulation of NFκB gene expression in the same model (FOXO1 and TNKS2 effects were reported for the related peptides KED and KE, not AED) [2]. At the whole-animal level, in aged rats, AED administration was associated with reduced proteinuria and increased diuresis [3], making Cartalax a reference compound in preclinical connective-tissue and cellular-aging research examining chondrogenic differentiation, regulation of IGF1 and associated gene expression, and morphofunctional changes in aged tissue.
Cartalax is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Research
Khavinson Bioregulators: Investigations on Short Peptide Research
Select Size
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






